178 related articles for article (PubMed ID: 36075586)
1. Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.
Tanner KT; Daniel RM; Bilton D; Simmonds NJ; Sharples LD; Keogh RH
Diabet Med; 2022 Nov; 39(11):e14958. PubMed ID: 36075586
[TBL] [Abstract][Full Text] [Related]
2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of cystic fibrosis-related diabetes.
Marshall BC; Butler SM; Stoddard M; Moran AM; Liou TG; Morgan WJ
J Pediatr; 2005 May; 146(5):681-7. PubMed ID: 15870674
[TBL] [Abstract][Full Text] [Related]
4. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
5. Cystic Fibrosis-Related Diabetes in Children: An Update.
Kim RJ
Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
[TBL] [Abstract][Full Text] [Related]
6. The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: A CF patient registry study.
Franck Thompson E; Watson D; Benoit CM; Landvik S; McNamara J
J Cyst Fibros; 2020 Mar; 19(2):316-320. PubMed ID: 31439463
[TBL] [Abstract][Full Text] [Related]
7. Screening for cystic fibrosis-related diabetes: a systematic review.
Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis-related diabetes before lung transplantation is associated with lower survival but does not affect long-term renal function.
Mainbourg S; Philit F; Touzet S; Nove-Josserand R; Durupt S; Sénéchal A; Occelli P; Poupon-Bourdy S; Maury JM; Tronc F; Mornex JF; Durieu I; Reynaud Q
Pediatr Pulmonol; 2019 Jul; 54(7):977-983. PubMed ID: 30854801
[TBL] [Abstract][Full Text] [Related]
9. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of cystic fibrosis related diabetes.
Moheet A; Moran A
Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
Hameed S; Jaffé A; Verge CF
Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of paediatric cystic fibrosis-related diabetes.
Perrem L; Stanojevic S; Solomon M; Carpenter S; Ratjen F
J Cyst Fibros; 2019 Nov; 18(6):874-878. PubMed ID: 31072797
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of cystic fibrosis-related diabetes: Data from two different sources the European cystic fibrosis society patient registry and German/Austrian diabetes prospective follow-up registry.
Prinz N; Zolin A; Konrad K; Nährlich L; Laubner K; Olesen HV; Bauer M; Jung A; Frischer T; Holl RW;
Pediatr Diabetes; 2019 May; 20(3):255-262. PubMed ID: 30761696
[TBL] [Abstract][Full Text] [Related]
15. Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections.
Belle-van Meerkerk G; de Valk HW; Stam-Slob MC; Teding van Berkhout F; Zanen P; van de Graaf EA
Diabetes Res Clin Pract; 2016 Jun; 116():230-6. PubMed ID: 27321340
[TBL] [Abstract][Full Text] [Related]
16. Nutritional status between 5-10 years is associated with cystic fibrosis-related diabetes in adolescence.
Ararat E; Sonawalla A; Berlinski A; Tas E
Pediatr Pulmonol; 2021 Oct; 56(10):3217-3222. PubMed ID: 34245493
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
18. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
19. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
[TBL] [Abstract][Full Text] [Related]
20. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
